Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
xen1101 save search
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-16 (Crawled : 13:00) - globenewswire.com
XENE | $40.01 1.1K
|
Health Technology
|
| O: 0.0%
H: 1.73%
C: 0.44%
xen1101 neurology pharmaceuticals meeting
Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD)
Published: 2023-11-27 (Crawled : 12:00) - globenewswire.com
XENE | $40.01 1.1K
|
Health Technology
|
| O: 0.1%
H: 18.14%
C: 17.66%
xen1101 pharmaceuticals topline trial results
Xenon Pharmaceuticals Announces Publication of Results from XEN1101 Phase 2b “X-TOLE” Clinical Trial in Peer-Reviewed Journal Article in JAMA Neurology
Published: 2023-10-09 (Crawled : 20:00) - globenewswire.com
XENE | $40.01 1.1K
|
Health Technology
|
| O: 0.31%
H: 3.31%
C: 3.06%
xen1101 publication pharmaceuticals trial results
Xenon Pharmaceuticals Announces Upcoming Investor Webinar with Leading Key Opinion Leaders to Discuss XEN1101 and Major Depressive Disorder
Published: 2023-09-12 (Crawled : 21:00) - globenewswire.com
XENE | $40.01 1.1K
|
Health Technology
|
| O: 0.72%
H: 0.96%
C: -1.55%
xen1101 pharmaceuticals
Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress
Published: 2023-09-04 (Crawled : 12:30) - globenewswire.com
XENE | $40.01 1.1K
|
Health Technology
| Email alert
Add to watchlist
xen1101 congress international pharmaceuticals program
Xenon Pharmaceuticals Showcases Its XEN1101 Epilepsy Program at the 2023 American Academy of Neurology (AAN) Annual Meeting
Published: 2023-04-24 (Crawled : 12:20) - biospace.com/
XENE | $40.01 1.1K
|
Health Technology
|
| O: 0.61%
H: 0.93%
C: -0.93%
xen1101 pharmaceuticals meeting program
Xenon Pharmaceuticals Announces Launch of XEN1101 Phase 3 Program with Initiation of X-TOLE2 Clinical Trial in Patients with Focal Onset Seizures
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
XENE | $40.01 1.1K
|
Health Technology
|
| O: -0.92%
H: 1.75%
C: -0.05%
xen1101 pharmaceuticals trial
Xenon Pharmaceuticals Provides Update on Additional Positive Data from the XEN1101 Program
Published: 2022-06-22 (Crawled : 21:00) - biospace.com/
XENE | $40.01 1.1K
|
Health Technology
|
| O: 7.12%
H: 0.0%
C: 0.0%
xen1101 program positive update
Xenon Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial to Evaluate XEN1101 as a Treatment for Major Depressive Disorder (MDD)
Published: 2022-05-03 (Crawled : 19:00) - biospace.com/
XENE | $40.01 1.1K
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
xen1101 treatment trial phase 2 major depressive disorder
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101
Published: 2021-10-03 (Crawled : 00:00) - globenewswire.com
XENE | $40.01 1.1K
|
Health Technology
|
| O: 69.5%
H: 22.03%
C: 18.82%
phase 2 results topline phase 2b trial conference
Xenon Pharmaceuticals Announces Completion of Patient Randomization in XEN1101 and Upcoming Investor Webinar
Published: 2021-07-07 (Crawled : 13:15) - biospace.com/
XENE | $40.01 1.1K
|
Health Technology
|
| O: -0.05%
H: 2.15%
C: 0.38%
Xenon Pharmaceuticals Announces Completion of Patient Randomization in XEN1101 Phase 2b “X-TOLE” Clinical Trial and Announces Upcoming Investor Webinar with Leading Epilepsy Key Opinion Leaders
Published: 2021-07-07 (Crawled : 13:00) - globenewswire.com
XENE | $40.01 1.1K
|
Health Technology
|
| O: -0.05%
H: 2.15%
C: 0.38%
phase 2 phase 2b trial
Xenon Pharmaceuticals Announces Promising New Pre-Clinical Data and Provides Clinical Overview of its XEN1101 Program at ASENT 2021
Published: 2021-02-22 (Crawled : 21:03) - globenewswire.com
XENE | $40.01 1.1K
|
Health Technology
|
| O: -2.13%
H: 6.91%
C: 3.39%
preclinical pre-clinical
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
MTTR | News M | $4.625 165.81% 5.5M
|
AGBA | $2.615 109.2% 14M
|
Finance
EDBL | News | $7.37 96.01% 650K
|
PALI | $7.64 54.97% 14M
|
Manufacturing
OPRT | News | $3.19 41.78% 3M
|
Finance
PEGY | $0.0629 37.34% 110M
|
Manufacturing
MLEC | $1.87 33.57% 1.6M
|
n/a
ATGL | $3.66 27.97% 150K
|
VNRX | $0.759 26.5% 390K
|
Health Technology
SMFL | $5.35 22.99% 11M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.